Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedJul 17, 2019Hydroxocobalamin 10 mg/mL InjectionLack of Assurance of Sterility.First Pharma Associates LLC dba Riverpoint Pharmacy · D-1476-2019Class IITerminatedJul 17, 2019Prostaglandin 20 mcg/mL/Procaine 0.1% InjectionLack of Assurance of Sterility.First Pharma Associates LLC dba Riverpoint Pharmacy · D-1475-2019Class IITerminatedJul 17, 2019Hydroxyprogesterone Caproate 250 mg/mL Sesame Oil InjectionLack of Assurance of Sterility.First Pharma Associates LLC dba Riverpoint Pharmacy · D-1474-2019Class IITerminatedJul 17, 2019Testosterone Cyp/Estradiol Cyp 50 mg/2.5 mg/mL InjectionLack of Assurance of Sterility.First Pharma Associates LLC dba Riverpoint Pharmacy · D-1473-2019Class IITerminatedJul 17, 2019Testosterone Cypionate 100 mg/mLOil Injection InjectionLack of Assurance of Sterility.First Pharma Associates LLC dba Riverpoint Pharmacy · D-1472-2019Class IITerminatedJul 17, 2019Testosterone Cypionate 200 mg/mL Ethyl Oleate InjectionLack of Assurance of Sterility.First Pharma Associates LLC dba Riverpoint Pharmacy · D-1471-2019Class IITerminatedJul 17, 2019Testosterone Cypionate 200 mg/mL Sesame Oil InjectionLack of Assurance of Sterility.First Pharma Associates LLC dba Riverpoint Pharmacy · D-1470-2019Class IITerminatedJul 17, 2019Testosterone Cypionate 150 mg/mL Sesame Oil InjectionLack of Assurance of Sterility.First Pharma Associates LLC dba Riverpoint Pharmacy · D-1469-2019Class IITerminatedJul 17, 2019Testosterone Cypionate 100 mg/mL Sesame Oil InjectionLack of Assurance of Sterility.First Pharma Associates LLC dba Riverpoint Pharmacy · D-1468-2019Class IITerminatedJul 17, 2019Anastrozole TabletsGMP Deviations: Potential cross contamination due to cleaning procedure failure.American Health Packaging · D-1467-2019Class IITerminatedJul 17, 2019Losartan Potassium TabletsCGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at...Major Pharmaceuticals · D-1466-2019Class IITerminatedJul 17, 2019Losartan PotassiumCGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.Golden State Medical Supply Inc. · D-1465-2019Class IITerminatedJul 17, 2019Losartan PotassiumCGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.Golden State Medical Supply Inc. · D-1464-2019Class IITerminatedJul 17, 2019Losartan PotassiumCGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.Golden State Medical Supply Inc. · D-1463-2019Class IITerminatedJul 17, 2019Losartan PotassiumCGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.Golden State Medical Supply Inc. · D-1462-2019Class IITerminatedJul 17, 2019Losartan Potassium andHydrochlorothiazide Tablets 100 mg/25 mg 90 tabletsCGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.Macleods Pharma Usa Inc · D-1461-2019Class IITerminatedJul 17, 2019Losartan Potassium and Hydrochlorothiazide TabletsCGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.Macleods Pharma Usa Inc · D-1460-2019Class IITerminatedJul 17, 2019Losartan Potassium and Hydrochlorothiazide TabletsCGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.Macleods Pharma Usa Inc · D-1459-2019Class IITerminatedJul 17, 2019Losartan Potassium Tablets 50 mg 1000 TabletsCGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.Macleods Pharma Usa Inc · D-1458-2019Class IITerminatedJul 17, 2019Losartan Potassium TabletsCGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.Macleods Pharma Usa Inc · D-1457-2019Class IIOngoingJul 17, 2019LOSARTAN POTASSIUM 100 mg TABLET BULKCGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.Teva Pharmaceuticals USA · D-1456-2019Class IIOngoingJul 17, 2019LOSARTAN POTASSIUM 50 mg TABLET BULKCGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.Teva Pharmaceuticals USA · D-1455-2019Class ITerminatedJul 10, 2019Hydromorphone HCl in 0.9% sodium chlorideIncorrect Product Formulation; Firm's customer resource center (CRC) statement indicates that the product is sulfite free, however the product is produced with a raw...PharMEDium Services, LLC · D-1488-2019Class IIITerminatedJul 10, 2019Testosterone Topical Solution 30mg of testosterone per pump actuation * each actuation delivers 1.5 mL of...Defective Container; actuator may improperly function and affect dose delivery.InvaGen Pharmaceuticals, Inc. · D-1454-2019Class IIITerminatedJul 10, 2019Esterified Estrogens & Methyltestosterone TabletsSubpotent Drug: Out of specification assay result in Esterified Estrogen and Methyltestosterone tablets.Amneal Pharmaceuticals, Inc. · D-1439-2019Class IIITerminatedJul 10, 2019Esterified Estrogens & Methyltestosterone TabletsSubpotent Drug: Out of specification assay result in Esterified Estrogen and Methyltestosterone tablets.Amneal Pharmaceuticals, Inc. · D-1438-2019Class IITerminatedJul 3, 2019Pramipexole Dihydrochloride TabletsGMP Deviations; possible cross contamination of product due to cleaning procedure failure.American Health Packaging · D-1434-2019Class IITerminatedJul 3, 2019Pramipexole Dihydrochloride TabletsGMP Deviations; possible cross contamination of product due to cleaning procedure failure.American Health Packaging · D-1433-2019Class IITerminatedJul 3, 2019Pramipexole Dihydrochloride TabletsGMP Deviations; possible cross contamination of product due to cleaning procedure failure.American Health Packaging · D-1432-2019Class IITerminatedJul 3, 2019Pramipexole Dihydrochloride TabletsGMP Deviations; possible cross contamination of product due to cleaning procedure failure.American Health Packaging · D-1431-2019Class IITerminatedJul 3, 2019Diphenhydramine HCL LiquidMicrobial Contamination of Non-sterile Products: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).H J Harkins Company Inc dba Pharma Pac · D-1430-2019Class IITerminatedJul 3, 2019Acetaminophen Children's LiquidMicrobial Contamination of Non-sterile Products: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).H J Harkins Company Inc dba Pharma Pac · D-1429-2019Class IITerminatedJul 3, 2019SUCCINYLcholine ChlorideLack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations...Premier Pharmacy Labs Inc · D-1428-2019Class IITerminatedJul 3, 2019SUCCINYLcholine ChlorideLack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations...Premier Pharmacy Labs Inc · D-1427-2019Class IITerminatedJul 3, 2019Sodium Bicarbonate INJ 8.4%Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations...Premier Pharmacy Labs Inc · D-1426-2019Class IITerminatedJul 3, 2019Riboflavin 5-Phosphate Sodium Ophthalmic SolutionLack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations...Premier Pharmacy Labs Inc · D-1425-2019Class IITerminatedJul 3, 2019Phenylephrine HCL PF INJ in 0.9% Sodium ChlorideLack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations...Premier Pharmacy Labs Inc · D-1424-2019Class IITerminatedJul 3, 2019Orphenadrine Citrate Sterile Injectable Solution *Contains Sulfites*Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations...Premier Pharmacy Labs Inc · D-1423-2019Class IITerminatedJul 3, 2019Neostigmine MethylsulfateLack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations...Premier Pharmacy Labs Inc · D-1422-2019Class IITerminatedJul 3, 2019Naloxone HCL Preserved INJLack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations...Premier Pharmacy Labs Inc · D-1421-2019

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.